GoMacro introduces nutrition bars with Omega-3
VIOLA, Wis. GoMacro on Wednesday announced the launch of Omega-3 MacroNutrient Bars that will be available in three flavors: banana almond crunch, cashew mesquite and chocolate crunch.
“We have created bars that are not only delicious but also low in sugar and carbs and high in Omega-3, fiber, vitamins and minerals,” stated Amelia Kirchoff, GoMacro co-founder. “Whether you need a high protein, gluten-free or low glycemic meal replacement you will find it in MacroNutrient Bars.”
GoMacro products are currently distributed through health food and specialty stores throughout the United States and Canada.
Supplement company to pay $2.5 million to FTC
WASHINGTON A dietary supplement maker has agreed to pay $2.5 million to settle a Federal Trade Commission charge of false advertising, the FTC announced Tuesday.
The FTC filed a complaint against the North American Herb & Spice Co. and owner Judy Kay Gray, alleging that the company falsely claimed that three of its oregano-based supplements—Oreganol P73, Super Strength Oreganol P73 and Oregacyn—were scientifically proven to prevent or treat colds and the flu, strengthen the immune system and kill germs ranging from mold and yeast to hepatitis C and avian bird flu virus.
Under the settlement, the company is forbidden from making said claims about their products unless they are true, not misleading and based on reliable scientific evidence.
Study shows Type 2 diabetics respond well to timely weight loss
A study published online Tuesday in the journal Diabetes Care indicates that people recently diagnosed with Type 2 diabetes can retain better control of their blood pressure and sugar by losing weight soon after diagnosis.
The study looked at 2,574 patients aged 21 through 75 with recent diabetes diagnoses over a five-year period starting in 1997. The 12 percent of patients classed in the “weight loss” group—those who had lost an average of more than 25 pounds—were more likely to have control over their blood pressure and sugar.
Type 2 diabetes affects more than 20 million Americans.